Paterson Building Development Update – May 2021
As the building reaches the fourth floor, Professor Nic Jones, Director of Strategic Initiatives at the MCRC updates in the first of our new quarterly updates. Read More
As the building reaches the fourth floor, Professor Nic Jones, Director of Strategic Initiatives at the MCRC updates in the first of our new quarterly updates. Read More
Rob Bristow updates about the first months of 2021 from the MCRC including grant submissions, awards and accolades for our academic researchers, and multiple events on the horizon. Read More
The first proton beam therapy clinical trial in the UK is now taking place at The Christie NHS Foundation Trust in Manchester. Read More
On International Women's Day, we choose to celebrate the achievements of women and raise awareness about women’s equality across the globe. Colleagues from across the MCRC share how they are helping to address inequalities through their role and research, as well as identifying how else we can ensure equality throughout our partnerships. Today, we #ChooseToChallenge. Read More
A new research development from The University of Manchester and the Christie NHS Foundation Trust has shown progress for developing a potential new cancer treatment using high energy electron beams. Read More
A simple non-invasive test can accurately detect womb cancer according to a proof of concept study by University of Manchester and Manchester University NHS Foundation Trust (MFT) scientists. Read More
Her PhD involves developing ex vivo models for breast cancer, to define how differential tissue composition and mechanics drive genetic instability in breast cancer initiation. Read More
Her PhD investigates NK cell control of tumour growth dependent upon the inflammatory environment. Read More
Manchester poet Tony Walsh underlines the love, dedication and Manchester’s cancer expertise in his latest work ‘Innit, love?’ released to mark Greater Manchester’s response to World Cancer Day. Read More
She’s doing a non-clinical PhD to investigate the biological effects of proton therapy in lung cancer. Read More
Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of their disease returning and should be adopted as the new standard of care, a new study shows. Read More
She’s a Senior Specialist Registrar in Obstetrics & Gynaecology and is undertaking a clinical PhD, jointly funded by Cancer Research UK and the NIHR. Read More
Gemma is an NIHR Clinical Lecturer investigating predictive and therapeutic biomarkers for tumour infiltrating lymphocyte (TIL) therapy. Read More
He’s a Specialist Registrar in Radiology and is undertaking a clinical PhD which is funded by Cancer Research UK. Read More